Cancer Immunity & Immunotherapy

Wednesday, June 14, 2017, 8:00 AM - 5:00 PM CT

Presented by the Federation of Clinical Immunology Societies (FOCIS) and the Society for Immunotherapy of Cancer

sitc_log_color.png

Held during the FOCIS Annual Meeting on June 14-17, this course will review tumor immunology as the foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations, and opportunities for furthering clinical progress.

Translational researchers, practicing clinicians, trainees, and individuals from pharmaceutical companies may register for this course alone or in combination with the FOCIS Annual Meeting. Contact education@sitcancer.org to obtain information on discounted registration rates for SITC members.

Learn more and register for this program here.


Session Speakers and Topics

8 a.m. – 12 p.m. Session I: Immunity to Cancer, Adoptive Cell Therapy
8 – 9 a.m. The Mechanistic Basis of Cancer Immunotherapy
Leisha Emens, MD, PhD – Johns Hopkins University
9 – 9:40 a.m. Manipulating the Tumor Environment (DCs, Tregs, Others)

Vincenzo Bronte, MD – University of Verona

9:40 – 10 a.m. Break
10 – 10:40 a.m. CAR-T Cell Therapy: Principles and Current Practices
Carl H. June, MD –University of Pennsylvania
10:40 – 11:20 a.m. CAR-T Cell Therapy: Next Generation CARs Toxicities, Challenges and Prospects
Carl H. June, MDUniversity of Pennsylvania
11:20 a.m. – noon TCR-based Adoptive Cell Therapy

Cassian Yee, MD – University of Texas MD Anderson Cancer Center

noon – 12:45 p.m. Lunch with Faculty
12:45 – 6 p.m. Session II: Checkpoint Blockade, Combination Therapies

12:45 – 1:30 p.m. Checkpoint Blockade Therapy: Current Status, Biomarkers
Hassane M. Zarour, MD – University of Pittsburgh
1:30 – 2:10 p.m. Next Generation Checkpoint and Combination Therapies
Hassane M. Zarour, MD – University of Pittsburgh
2:10 – 2:50 p.m. Focus on Engineered Antibodies (BiTE/Other)
Dario Neri, PhD – Swiss Federal Institute of Technology Zurich
2:50 – 3:30 p.m. Immune-Related Toxicity: Mechanisms and Management

Kevan Herold, MD – Yale University

3:30 – 3:45 p.m. Break
3:45 – 4:30 p.m. Vaccination Strategies, Identification of Neoantigens
Catherine Wu, MD – Dana-Farber Cancer Institute
4:30 – 5 p.m. Future Prospects and Challenges in Cancer Immunotherapy
Jeffrey A. Bluestone, PhD – University of California San Francisco

Location

Hilton Chicago Hotel
Chicago, IL

Tags

  • Source
  • Collaboration
  • User Type
  • Clinician
  • Industry
  • Researcher
  • Year
  • 2017